You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Implementing Pre-Exposure Prophylaxis Against SARS-CoV-2 for Immunocompromised Patients

  • Authors: Andrew Ustianowski, MBBS; Alexandra L. Calmy, MD, PhD, FMH; Howard J Huang, MD
  • CME Released: 12/15/2022
  • Valid for credit through: 12/15/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for infectious disease and HIV specialists, primary care physicians, nephrologists, hematology/oncology specialists, allergists and clinical immunologists, pulmonologists, and transplant surgeons.

The goal of this activity is for learners to be better able to ensure that clinicians understand which patient groups will benefit from pre-exposure prophylaxis with monoclonal antibodies (mAbs) for COVID-19 and be able to provide practical guidance for implementation of these therapies for appropriate patients.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical data for mAbs for pre-exposure prophylaxis (PrEP) to SARS-CoV-2
    • Best practice on implementing PrEP in clinical practice
  • Have greater competence related to
    • Identifying patients who might benefit from PrEP


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Moderator

  • Andrew Ustianowski, MBBS

    Consultant Physician
    Regional Infectious Diseases Unit
    North Manchester General Hospital
    Manchester, United Kingdom

    Disclosures

    Andrew Ustianowski, MBBS, has the following relevant financial relationships:
    Consultant or advisor for: Gilead Sciences; GlaxoSmithKline; Merck; ViiV Healthcare
    Speaker or member of speakers bureau for: Gilead Sciences; GlaxoSmithKline; Merck; Sanofi; ViiV Healthcare
    Research funding from: Gilead; Merck; ViiV Healthcare; Vir

Faculty

  • Alexandra L. Calmy, MD, PhD, FMH

    Assistant Professor
    Director of the HIV/AIDS Unit
    Division of Infectious Diseases
    Geneva University Hospitals
    Geneva, Switzerland

    Disclosures

    Alexandra L. Calmy, MD, PhD, FMH, has the following relevant financial relationships:
    Research funding from: Merck Sharp & Dohme
    Other: Education grants received from Gilead; Merck Sharp & Dohme; ViiV Healthcare

  • Howard J Huang, MD

    Chief, Section of Lung Transplantation
    Medical Director of the Houston Methodist Lung Transplant Center
    Houston Methodist Hospital
    Houston, Texas, United States

    Disclosures

    Howard J Huang, MD, MD, has the following relevant financial relationships:
    Consultant or advisor for: ATARA Biotherapeutics, CareDX, Lung BioEngineering; Regeneron Pharmaceuticals; Zambon
    Speaker or member of speakers bureau for: Boehringer Ingelheim
    Research funding from: Bristol Myers Squibb
    Contracted researcher for: Ansun Biopharma; Lilly; Natera; Regeneron Pharmaceuticals; Zambon

Editor

  • Shanthi Voorn, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Shanthi Voorn, PhD, has no relevant financial relationships.

  • Diana Lucifero, PhD

    Scientific Content Manager, WebMD Global, LLC

    Disclosures

    Diana Lucifero, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Implementing Pre-Exposure Prophylaxis Against SARS-CoV-2 for Immunocompromised Patients

Authors: Andrew Ustianowski, MBBS; Alexandra L. Calmy, MD, PhD, FMH; Howard J Huang, MDFaculty and Disclosures

CME Released: 12/15/2022

Valid for credit through: 12/15/2023

processing....

Transkription in Deutsch

Download the pdf.

« Return to: Implementing Pre-Exposure Prophylaxis Against SARS-CoV-2 for Immunocompromised Patients
  • Print